rs4958847

JAK2 variant rs10758669 significantly increases susceptibility to Crohn's disease (p=0.026, OR=1.25) and is associated with increased intestinal permeability (p=0.004, OR=2.996), suggesting a barrier dysfunction mechanism in IBD pathogenesis. STAT3 rs744166 also increased CD risk (p=0.04, OR=0.83), while IRGM variants showed no association with disease. The findings highlight JAK2's role in epithelial barrier function independent of NOD2 genotype.

This case-control study in a Chinese Han population evaluated eight IBD susceptibility loci previously identified in European GWAS. The study found that NOD2 P268S contributed to Crohn's disease susceptibility (P=0.025), IL23R rs11805303 conferred protective effect against ulcerative colitis (P=0.010), and PTPN2 rs2542151 was associated with increased UC risk (P=0.001). Phenotype-genotype analysis showed P268S was associated with early-onset disease and ileal involvement in CD patients.

This paper presents a statistical method for unbiased estimation of odds ratios from genome-wide association scans combined with replication studies. The authors develop a Uniformly Minimum Variance Conditionally Unbiased Estimator (UMVCUE) that corrects for selection bias arising from both rank ordering and significance thresholding in initial scans. Applied to type 1 diabetes and Crohn's disease data from the Wellcome Trust Case Control Consortium, the method shows improved efficiency over replication-only estimates, particularly when replication sample sizes are smaller.

A meta-analysis of 4,107 type 2 diabetes cases and 5,187 controls from three GWA studies found no evidence that common variants altering circulating inflammatory protein levels (IL-18, IL-6R, CRP, IL1RN, PAI1, MIF) or variants predisposing to autoimmune diseases (type 1 diabetes, rheumatoid arthritis, Crohn's disease, celiac disease, multiple sclerosis, SLE) are associated with type 2 diabetes risk. For example, rs2250417 in IL18 showed OR=1.00 (95% CI 0.99-1.03) versus the expected OR of ~1.15 if inflammation were causal, suggesting inflammatory markers are likely secondary rather than causative in type 2 diabetes.